R.PR
REGISTERED-PRINCIPAL REGISTER
12/07/2021
Back to search
Official data from USPTO
CLINICAL TRIAL HERO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINICAL TRIAL HERO
ST13
US500000090142594Class
9
Filing
90142594
Registration
6584624
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
12/07/2021
Trademark type
Word
Nice classes
9
Filing date
08/27/2020
Registration date
12/07/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/07/2021
Last transaction
12/07/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/27/2020
First use in commerce
11/30/2020
Drawing code
4
Owner type
03
Owner location
Calgary, AB, CA
Examiner
LEE, JEANIE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
M. C. (pessoa física)
Representatives
Justin Brown BROWN BROTHERS LAW LLP
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software and mobile applications for use in database managementuse in electronic storage of data in the field of instruction for meditation and clinical trial enrollment; Downloadable computer software and mobile applications for guided meditation instruction and featuring downloadable white noise soundspa soundmusical sound recordingsaudio-visual recordings featuring guided meditation instructiondownloadable multimedia files containing artworkaudiovideotext relating to meditation; Downloadable software in the nature of a mobile application for use in database managementfor use as a spreadsheetfor word processing in the field of meditation and clinical trial search
Publications
History of USPTO decisions and trademark events.
34 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/05/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/22/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/07/2021
GNFR
FINAL REFUSAL E-MAILED
09/07/2021
CNFR
SU - FINAL REFUSAL - WRITTEN
09/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2021
ALIE
ASSIGNED TO LIE
07/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2021
GNRT
NON-FINAL ACTION E-MAILED
07/02/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/02/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/20/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/20/2021
IUAF
USE AMENDMENT FILED
05/10/2021
EISU
TEAS STATEMENT OF USE RECEIVED
05/10/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBO
PUBLISHED FOR OPPOSITION
03/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2021
GNRT
NON-FINAL ACTION E-MAILED
01/05/2021
CNRT
NON-FINAL ACTION WRITTEN
01/05/2021
DOCK
ASSIGNED TO EXAMINER
12/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2020
NWAP
NEW APPLICATION ENTERED
08/31/2020
Continuous trademark protection
Get notified about every new filing that threatens CLINICAL TRIAL HERO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.